Atrium Therapeutics, Inc. · NASDAQ:RNA
Ra Capital Management, L.P.'s stake in Atrium Therapeutics, Inc. fell below 5% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Ra Capital Management, L.P.'s stake in Atrium Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 0% | 0 |
| Peter Kolchinsky | 0% | 0 |
| Rajeev Shah | 0% | 0 |
| RA Capital Healthcare Fund, L.P. | 0% | 0 |
Source
Related
- Atrium Therapeutics, Inc.
- Ra Capital Management, L.P.
- Atrium Therapeutics, Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · May 15, 2026
- Form 4 · Younis Husam · Sep 22, 2026
- Form 4 · Hughes Steven George · Sep 22, 2026
- Form 4 · Flanagan W. Michael · Sep 22, 2026
- Form 4 · Boyce Sarah · Sep 22, 2026
- Form 4 · Kenney Stephanie · Sep 22, 2026